Neuroone Medical Technologies (NMTC) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.72% |
| Dec 31, 2025 | 6.00% |
| Sep 30, 2025 | -16.50% |
| Jun 30, 2025 | 26.70% |
| Mar 31, 2025 | -11.03% |
| Dec 31, 2024 | 18.99% |
| Sep 30, 2024 | -19.88% |
| Jun 30, 2024 | -8.24% |
| Mar 31, 2024 | -5.24% |
| Jun 30, 2023 | -24.23% |
| Mar 31, 2023 | -26.27% |
| Dec 31, 2022 | -17.50% |
| Sep 30, 2022 | -8.99% |
| Jun 30, 2022 | -25.44% |
| Mar 31, 2022 | -222.59% |
| Dec 31, 2021 | -219.69% |
| Sep 30, 2021 | -241.28% |
| Jun 30, 2021 | -191.15% |
| Mar 31, 2021 | -252.70% |
| Dec 31, 2020 | -194.62% |
| Sep 30, 2020 | 432.27% |
| Jun 30, 2020 | -228.19% |
| Mar 31, 2020 | -158.83% |
| Jun 30, 2019 | -158.89% |
| Mar 31, 2019 | -249.72% |
| Jun 30, 2018 | -127.77% |
| Mar 31, 2018 | -219.28% |
| Dec 31, 2017 | -252.34% |
| Sep 30, 2017 | -184.68% |
| Jun 30, 2017 | -227.72% |
| Mar 31, 2017 | -9.45% |
| Dec 31, 2016 | 11.53% |
| Sep 30, 2016 | -6.45% |
| Jun 30, 2016 | -63.16% |
| Mar 31, 2016 | 8.10% |
| Dec 31, 2015 | -74.41% |
| Sep 30, 2015 | 13.01% |